SEC Form 4 · accession 0001214659-16-010592
NEULION, INC. · NLN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nancy Li
Officer — Executive Vice Chairman · Director · 10% Owner
Period of report
Mar 29, 2016
Accepted (ET)
Mar 31, 2016 · 5:41 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001387713
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2,F7 | Mar 29, 2016 | P | 63,930 | $0.7821 | A | 51,687,437 | I | By spouse |
| Common StockF3,F7 | Mar 29, 2016 | P | 1,500,000 | $0.8695 | A | 53,187,437 | I | By spouse |
| Common Stock | holding | — | — | — | 40,150,056 | D | ||
| Common StockF4 | holding | — | — | — | 28,020 | I | By trust for benefit of child | |
| Common StockF4 | holding | — | — | — | 28,020 | I | By trust for benefit of child | |
| Restricted Common StockF5 | holding | — | — | — | 750,000 | D | ||
| Restricted Common StockF6 | holding | — | — | — | 750,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Ms. Li's spouse, Charles B. Wang, the Chairman of the Board of NeuLion, purchased these shares from J. Christopher Wagner, the Executive Vice President, Marketplace Strategy, of NeuLion.
- F2The purchase price of each share was $0.7821, which was the 5 day volume weighted average price of NeuLion's common stock on the Toronto Stock Exchange ending March 28, 2016.
- F3Multiple same-way open market purchases effected on the same day within a one dollar price range are reported on this line. The figure in the price column is the weighted average purchase price for these transactions. These trades were executed on the Aequitas NEO Exchange, Alpha ATS, Nasdaq CX, Nasdaq CX2, TriAct MATCH Now, Omega ATS, Canadian Securities Exchange and the Toronto Stock Exchange, and the purchase prices were in Canadian dollars. The purchase price per share for each trade was between Cdn$1.09 and Cdn$1.16. The purchase prices were converted to US dollars by the executing broker, Merrill Lynch, at a rate of 0.7591. The reporting person undertakes to provide, upon request by the Commission staff, NeuLion, Inc., or a security holder of NeuLion, Inc., full information regarding the number of shares purchased at each separate price.
- F4Ms. Li is the trustee for the two trusts and her children are the beneficiaries of the trusts.
- F5The reporting person was granted these restricted shares subject to the terms of the Amended and Restated NeuLion, Inc. 2012 Omnibus Securities and Incentive Plan. The restricted shares vest at a rate of one-quarter of their allotted amount per year over four years. Vesting began on March 7, 2016.
- F6The reporting person was granted these restricted shares subject to the terms of the Amended and Restated NeuLion, Inc. 2012 Omnibus Securities and Incentive Plan. The restricted shares vest at a rate of one-quarter of their allotted amount per year over four years. Vesting began on May 18, 2015.
- F7Ms. Li disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that Ms. Li is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.